For both new and experienced investors, maximizing stock market opportunities and investing confidently are common objectives. One way to simplify the process of finding great stocks is by using Zacks Style Scores. These scores evaluate stocks based on their value, growth, and momentum characteristics.
Growth investors focus on a company’s financial strength, overall health, and future outlook. They prioritize the Growth Style Score, which analyzes factors like projected and historical earnings, sales, and cash flow to identify stocks with sustainable growth potential.
One growth stock worth considering is ResMed, Inc. (RMD). ResMed is a leading designer, manufacturer, and distributor of generators, masks, and accessories for the treatment of sleep-disordered breathing and other respiratory disorders. The company holds a Zacks Rank #2 (Buy), with a Growth Style Score of A and a VGM Score of B. Earnings and sales are expected to increase by 19.6% and 10.5% year-over-year, respectively.
Several analysts have revised their earnings estimates higher for ResMed in the past 60 days, with the Zacks Consensus Estimate also seeing an increase. The company has a strong track record of earnings surprises, with an average surprise of 2.8%.
ResMed is financially sound, with a 12.8% growth in cash flow and an expected 9.8% expansion in 2024. With solid fundamentals, a favorable Zacks Rank, and impressive Growth and VGM Style Scores, ResMed is a stock that should be on investors’ radar.
For more investment recommendations, investors can download the latest report from Zacks Investment Research, featuring the 7 Best Stocks for the Next 30 Days.